PT65506B - Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines - Google Patents

Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines

Info

Publication number
PT65506B
PT65506B PT65506A PT6550676A PT65506B PT 65506 B PT65506 B PT 65506B PT 65506 A PT65506 A PT 65506A PT 6550676 A PT6550676 A PT 6550676A PT 65506 B PT65506 B PT 65506B
Authority
PT
Portugal
Prior art keywords
anthraquinonylene
amebic
cecal
amidines
infections
Prior art date
Application number
PT65506A
Other languages
English (en)
Portuguese (pt)
Other versions
PT65506A (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT65506A publication Critical patent/PT65506A/pt
Publication of PT65506B publication Critical patent/PT65506B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195Radicals derived from nitrogen analogues of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT65506A 1975-08-22 1976-08-20 Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines PT65506B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60680575A 1975-08-22 1975-08-22

Publications (2)

Publication Number Publication Date
PT65506A PT65506A (en) 1976-09-01
PT65506B true PT65506B (en) 1978-02-15

Family

ID=24429543

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65506A PT65506B (en) 1975-08-22 1976-08-20 Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines

Country Status (21)

Country Link
JP (1) JPS5225763A (el)
AR (1) AR213625A1 (el)
AU (1) AU508586B2 (el)
BE (1) BE845369A (el)
CA (1) CA1098127A (el)
CS (1) CS212773B2 (el)
DE (1) DE2637544A1 (el)
EG (1) EG12401A (el)
ES (1) ES450859A1 (el)
FR (1) FR2321281A1 (el)
GB (1) GB1553600A (el)
GR (1) GR60420B (el)
HU (1) HU173298B (el)
LU (1) LU75636A1 (el)
NL (1) NL7609230A (el)
NZ (1) NZ181596A (el)
PH (1) PH13216A (el)
PL (1) PL191945A1 (el)
PT (1) PT65506B (el)
SU (1) SU883002A1 (el)
ZA (1) ZA764516B (el)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154489B (de) * 1961-05-05 1963-09-19 Basf Ag Verfahren zur Trennung von Mono- und Diaminoanthrachinonen

Also Published As

Publication number Publication date
AR213625A1 (es) 1979-02-28
FR2321281A1 (fr) 1977-03-18
GR60420B (en) 1978-05-25
PL191945A1 (pl) 1978-12-04
PH13216A (en) 1980-02-07
NZ181596A (en) 1978-12-18
GB1553600A (en) 1979-09-26
JPS5225763A (en) 1977-02-25
HU173298B (hu) 1979-04-28
AU508586B2 (en) 1980-03-27
CS212773B2 (en) 1982-03-26
FR2321281B1 (el) 1979-07-27
EG12401A (en) 1980-03-31
BE845369A (fr) 1977-02-21
NL7609230A (nl) 1977-02-24
PT65506A (en) 1976-09-01
ZA764516B (en) 1977-07-27
SU883002A1 (ru) 1981-11-23
CA1098127A (en) 1981-03-24
DE2637544A1 (de) 1977-03-03
AU1669376A (en) 1978-02-16
LU75636A1 (el) 1977-03-29
ES450859A1 (es) 1978-04-01

Similar Documents

Publication Publication Date Title
CA1011738A (en) 2-(thienyl-3'-amino)-1,3-diaza-cycloalkenes and process for preparing them
FR2353030A1 (fr) Fours de traitement, notamment pour boites de conserves et analogues
BE847206A (fr) Procede et disposition pour le traitement themique de materiau pulverulent,
GB1544993A (en) Drying process and installation for drying workpieces
JPS51143519A (en) Steel sheets having modified charactor and articles made from the same
MY8200137A (en) 13,14-dehydro-11-deoxy-prostaglandins and process for their preparations
PT65506A (en) Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines
BE777062A (fr) 3-sulfo-alkyl-6-hydroxy-pyridones-(2), leur procede de preparation et application
NL7602144A (nl) Werkwijze voor de bereiding van 1,5-dimethylte- tralien en voor de bereiding van 1,5-dimethyl- naftaleen.
IL35113A (en) Cardenolide-3-(2',3',-didesoxyglycosides)and process for their preparation
AU3432971A (en) Substituted 2,2-biimidazoles and process for their preperation
GR61127B (en) Fortimicin c and process for the production thereof
CA623330A (en) 1,2,4-trithiolanes and process for making the same
FR2313036A1 (fr) Nouvelles thienyl-prostaglandines, leur procede de preparation et leur application
ZA713078B (en) 4,5-oxido-bufa-dienolido-3-(rhamnosido-2',3'-dialkylorthocarbonates)and process for their manufacture
ZA706003B (en) 5-aryl-3h-1,2,4-dithiazoles and process for their manufacture
CA825177A (en) Process for cyclodimerizing 1,2-oxiranes, 1,2-thiiranes and 1,2-aziridines
IL35093A (en) 2-(thienyl-3'-amino)-1,3-diaza-cycloalkenes and process for preparing them
CA845086A (en) Metal treating process and composition
CA612497A (en) 1,4-benzodiazepine 4-oxides and process for the manufacture thereof
CA847842A (en) Metal treating process
AU445972B2 (en) Metal treating process
CA898116A (en) Composition and process for treating metal
CA827665A (en) 4,8(14),9-gona-trien-3-ones and process
CA898667A (en) Metal treating composition and process